A. Streby

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “606 Focused clinical trials of modulator response for rare cystic fibrosis genotypes”.

606 Focused clinical trials of modulator response for rare cystic fibrosis genotypes

Journal of Cystic Fibrosis(2022)10.1016/s1569-1993(22)01296-6

N/A

0DataRank · unranked

0 citations

S. Suzuki, H. Hathorne, C. Barilla, B. Wang, A. Rab +14 more

280 Induced pluripotent stem cell–based airway epithelial platform for investigating personalized responses to CFTR modulators

Journal of Cystic Fibrosis(2023)10.1016/s1569-1993(23)01208-0

N/A

0DataRank · unranked

0 citations

András Rab, Shunji Suzuki, Richard Bertrand, Stefan Winkler, S. Ponnaluri +12 more

242 An open-label trial to evaluate elexacaftor-tezacaftor-ivacaftor and induced pluripotent stem cell–derived model systems in individuals with residual CFTR activity

Journal of Cystic Fibrosis(2023)10.1016/s1569-1993(23)01171-2

N/A

0DataRank · unranked

0 citations

George M. Solomon, Shingo Suzuki, András Rab, C. Barillà, Arlene A. Stecenko +11 more